ecNumber*3.4.21.22#kmValue*-999#kmValueMaximum*#substrate*more#commentary*kinetic determination of the affinity for factor IXa-factor VIIIa complex formation, effect of ethylene glycol at 30% on reaction kinetics, overview#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*-999#kmValueMaximum*#substrate*more#commentary*steady-state kinetics of wild-type and mutant enzymes n presence or absence of NaCl#organism*Homo sapiens#ligandStructureId*#literature*684024#!ecNumber*3.4.21.22#kmValue*0.000001#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant N178A the intrinsic tenase complex, in absence of ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.00000311#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIXa7omegaloop7EGF2, in the presence of phospholipid vesicles#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000052#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant R165A the intrinsic tenase complex, in absence of ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.0000068#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa90A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.0000073#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant K126A the intrinsic tenase complex, in absence of ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.0000085#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutants N129A and K132A, each in the intrinsic tenase complex, in absence of ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.00000864#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIX7EGF2, in the presence of phospholipid vesicles#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000089#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa107A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.0000096#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant wild-type enzyme the intrinsic tenase complex, in absence of ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.000011#kmValueMaximum*#substrate*Factor X#commentary*wild type FIXa, FX activation in presence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.000013#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/A95aK/K98T/Y177F/I213V/E219G, FX activation in presence of FVIIIa; plasma-derived FIXa, FX activation in presence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.000014#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T/Y177F, FX activation in presence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.000015#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T, FX activation in presence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.000016#kmValueMaximum*#substrate*Factor X#commentary*37&deg;C, pH 7.4, G94R mutant#organism*Homo sapiens#ligandStructureId*#literature*652345#!ecNumber*3.4.21.22#kmValue*0.000017#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T/Y177F/I213V/E219, FX activation in presence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.0000181#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa90A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.00002#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa104A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.0000216#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIX7EGF2, in the presence of SFLLRN-activated platelets#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000224#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa94A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.0000251#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa105A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.0000259#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIX7omegaloop, in the presence of SFLLRN-activated platelets#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000286#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIX7omegaloop, in the presence of phospholipid vesicles#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.00002877#kmValueMaximum*#substrate*Factor X#commentary*wild type enzyme, in the presence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0000295#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa91A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000034#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa107A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000037#kmValueMaximum*#substrate*Factor X#commentary*25&deg;C, pH 7.4, in the presence of phospholipid vesicle containing 79% phosphatidylcholine, 1% phosphatidylserine and 20% phosphatidylethanolamine#organism*Homo sapiens#ligandStructureId*#literature*649933#!ecNumber*3.4.21.22#kmValue*0.000038#kmValueMaximum*#substrate*Factor X#commentary*FIXa/FXa chimera in which the 39-loop of the protease is replaced with the corresponding loop of FXa, in TBS containing 0.1 mg/ml bovine serum albumin, 0.1% polyethylene glycol (PEG) 8000, and 5 mM Ca2+, at 22&deg;C, pH not specified in the publication#organism*Homo sapiens#ligandStructureId*#literature*717800#!ecNumber*3.4.21.22#kmValue*0.0000396#kmValueMaximum*#substrate*Factor X#commentary*plasma-derived FIXa, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.00004#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T/Y177F/I213V/E219, FX activation in absence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.0000405#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIXaN, in the presence of SFLLRN-activated platelets#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000428#kmValueMaximum*#substrate*Factor X#commentary*plasma-derived FIXa, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000048#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant K132A the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.0000502#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIXaN, in the presence of phospholipid vesicles#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.0000508#kmValueMaximum*#substrate*Factor X#commentary*chimera enzyme FIXa7omegaloop7EGF2, in the presence of SFLLRN-activated platelets#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.000054#kmValueMaximum*#substrate*Factor X#commentary*37&deg;C, pH 7.4#organism*Homo sapiens#ligandStructureId*#literature*652345#!ecNumber*3.4.21.22#kmValue*0.000055#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant wild-type enzyme the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.000055#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/A95aK/K98T/Y177F/I213V/E219G, FX activation in absence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.00005793#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410N, in the presence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.000061#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant N129A the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.0000629#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa91A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000064#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa94A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000065#kmValueMaximum*#substrate*Factor X#commentary*plasma-derived FIXa, FX activation in absence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.000067#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant R165A the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.000068#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T/Y177F, FX activation in absence of FVIIIa; wild type FIXa, FX activation in absence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.00006988#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410L, in the presence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.000071#kmValueMaximum*#substrate*Factor X#commentary*37&deg;C, pH 7.4, R94D mutant#organism*Homo sapiens#ligandStructureId*#literature*652345#!ecNumber*3.4.21.22#kmValue*0.000071#kmValueMaximum*#substrate*Factor X#commentary*wild type enzyme, in TBS containing 0.1 mg/ml bovine serum albumin, 0.1% polyethylene glycol (PEG) 8000, and 5 mM Ca2+, at 22&deg;C, pH not specified in the publication#organism*Homo sapiens#ligandStructureId*#literature*717800#!ecNumber*3.4.21.22#kmValue*0.0000751#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410H, in the presence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0000787#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa104A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.00008#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant N178A the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.00008#kmValueMaximum*#substrate*Factor X#commentary*factor IXabeta', 0.1 mg/ml phospholipids, factor VIIIa in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.00008#kmValueMaximum*#substrate*Factor X#commentary*variant protein factor IXaAL#organism*Homo sapiens#ligandStructureId*#literature*95346#!ecNumber*3.4.21.22#kmValue*0.00008004#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410A, in the presence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.000083#kmValueMaximum*#substrate*Factor X#commentary*mutant Y94F/K98T, FX activation in absence of FVIIIa#organism*Homo sapiens#ligandStructureId*#literature*709724#!ecNumber*3.4.21.22#kmValue*0.0000869#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa105A, 5 units/ml FVIIIa and extruded phosphatidylcholine-phosphatidylserine phospholipid vesicles supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.000089#kmValueMaximum*#substrate*Factor X#commentary*pH 7.4, 22&deg;C, recombinant mutant K126A the intrinsic tenase complex, in presence of 30% ethylene glycol#organism*Homo sapiens#ligandStructureId*#literature*683165#!ecNumber*3.4.21.22#kmValue*0.0001#kmValueMaximum*#substrate*Factor X#commentary*#organism*Homo sapiens#ligandStructureId*#literature*95346#!ecNumber*3.4.21.22#kmValue*0.00013#kmValueMaximum*#substrate*Factor X#commentary*25&deg;C, pH 7.4, in the presence of GIGAVLKVLTTGLPALISSWIKRKRQQ#organism*Homo sapiens#ligandStructureId*#literature*649923#!ecNumber*3.4.21.22#kmValue*0.00014#kmValueMaximum*#substrate*Factor X#commentary*#organism*Homo sapiens#ligandStructureId*#literature*669228#!ecNumber*3.4.21.22#kmValue*0.0001542#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme rFIXa89A, 5 units/ml FVIIIa and SFLLRN-activated platelets supplemented with bovine serum albumine (2 mg/ml) and 5 mM CaCl2, at 37 &deg;C#organism*Homo sapiens#ligandStructureId*#literature*669281#!ecNumber*3.4.21.22#kmValue*0.00017#kmValueMaximum*#substrate*Factor X#commentary*25&deg;C, pH 7.4, in the presence of TRYLRIHPQSWVHQIALRMEV#organism*Homo sapiens#ligandStructureId*#literature*649923#!ecNumber*3.4.21.22#kmValue*0.00017#kmValueMaximum*#substrate*Factor X#commentary*factor IXabeta', 0.1 mg/ml phospholipids in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.00018#kmValueMaximum*#substrate*Factor X#commentary*variant protein factor IXaCH#organism*Homo sapiens#ligandStructureId*#literature*95346#!ecNumber*3.4.21.22#kmValue*0.0002227#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410N, in the absence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0002241#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410A, in the absence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.000231#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410H, in the absence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0002328#kmValueMaximum*#substrate*Factor X#commentary*mutant enzyme E410L, in the absence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0004478#kmValueMaximum*#substrate*Factor X#commentary*wild type enzyme, in the absence of factor VIIIa, at pH 7.4 and 37&deg;C#organism*Homo sapiens#ligandStructureId*#literature*755584#!ecNumber*3.4.21.22#kmValue*0.0006#kmValueMaximum*#substrate*Factor X#commentary*Gla-domainless factor IXabeta', 0.1 mg/ml phospholipids, factor VIIIa in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.00063#kmValueMaximum*#substrate*Factor X#commentary*in the presence of 0.1 mM phospholipid and 5 mM Ca2+#organism*Homo sapiens#ligandStructureId*#literature*652114#!ecNumber*3.4.21.22#kmValue*0.0008#kmValueMaximum*#substrate*Factor X#commentary*Gla-domainless factor IXabeta', 0.1 mg/ml phospholipids in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.001#kmValueMaximum*#substrate*Factor X#commentary*Gla-domainless factor IXabeta' in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.0045#kmValueMaximum*#substrate*Factor X#commentary*in the presence of recombinant tissue factor protein and vesicles composed of 75% (w/w) L-alpha-phosphatidylcholine and 25% (w/w) L-alpha-phosphatidylserine#organism*Homo sapiens#ligandStructureId*#literature*669217#!ecNumber*3.4.21.22#kmValue*0.0239#kmValueMaximum*#substrate*Factor X#commentary*factor IXabeta' in activating mixture#organism*Bos taurus#ligandStructureId*#literature*95342#!ecNumber*3.4.21.22#kmValue*0.095#kmValueMaximum*#substrate*Factor X#commentary*25&deg;C, pH 7.4#organism*Homo sapiens#ligandStructureId*#literature*649923#!ecNumber*3.4.21.22#kmValue*0.3#kmValueMaximum*#substrate*Factor X#commentary*FIXa, in the absence of platelet surface#organism*Homo sapiens#ligandStructureId*#literature*667506#!ecNumber*3.4.21.22#kmValue*0.38#kmValueMaximum*#substrate*Factor X#commentary*25&deg;C, pH 7.4, in the presence of phospholipid vesicle containing 79% phosphatidylcholine, 1% phosphatidylserine and 20% phosphatidylethanolamine#organism*Homo sapiens#ligandStructureId*#literature*649933#!ecNumber*3.4.21.22#kmValue*0.5#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*wild type enzyme FIXa, in presence of 200 mM Na+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*1.2#kmValueMaximum*#substrate*L-Leu-Gly-L-Arg-4-nitroanilide#commentary*FIXa/FXa chimera in which the 39-loop of the protease is replaced with the corresponding loop of FXa, in 0.02 M Tris-HCl (pH 7.5) buffer containing 0.1 M NaCl, 0.1 mg/ml bovine serum albumin, 33% ethylene glycol, and 5 mM Ca2+, at 22&deg;C#organism*Homo sapiens#ligandStructureId*19573#literature*717800#!ecNumber*3.4.21.22#kmValue*1.43#kmValueMaximum*#substrate*methylsulfonyl-D-cyclohexylglycyl-Gly-Arg-p-nitroanilide#commentary*rFIXa, at pH 7.4, in the presence of 33% v/v ethylene glycol#organism*Homo sapiens#ligandStructureId*31544#literature*95341#!ecNumber*3.4.21.22#kmValue*1.7#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-Arg-4-nitroanilide#commentary*pH 7.5, 22&deg;C, in presence of 5 mM Ca2+ and 0.2 M ChCl#organism*Homo sapiens#ligandStructureId*5413#literature*684077#!ecNumber*3.4.21.22#kmValue*1.9#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*wild type enzyme FIXa#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*2.1#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*mutant enzyme FIXagamma225P#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*2.2#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-Arg-4-nitroanilide#commentary*pH 7.5, 37&deg;C, recombinant wild-type enzyme, in absence of NaCl; pH 7.5, 37&deg;C, recombinant wild-type enzyme, in presence of 0.2 M NaCl#organism*Homo sapiens#ligandStructureId*5413#literature*684024#!ecNumber*3.4.21.22#kmValue*2.2#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-Arg-4-nitroanilide#commentary*pH 7.5, 22&deg;C, in presence of 5 mM Ca2+ with or without presence of 0.2 M LiCl#organism*Homo sapiens#ligandStructureId*5413#literature*684077#!ecNumber*3.4.21.22#kmValue*2.3#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-Arg-4-nitroanilide#commentary*pH 7.5, 22&deg;C, in presence of 5 mM Ca2+ and 0.2 M NaCl#organism*Homo sapiens#ligandStructureId*5413#literature*684077#!ecNumber*3.4.21.22#kmValue*2.3#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-L-Arg-p-nitroanilide#commentary*#organism*Homo sapiens#ligandStructureId*33963#literature*652413#!ecNumber*3.4.21.22#kmValue*2.3#kmValueMaximum*#substrate*L-Leu-Gly-L-Arg-4-nitroanilide#commentary*wild type enzyme, in 0.02 M Tris-HCl (pH 7.5) buffer containing 0.1 M NaCl, 0.1 mg/ml bovine serum albumin, 33% ethylene glycol, and 5 mM Ca2+, at 22&deg;C#organism*Homo sapiens#ligandStructureId*19573#literature*717800#!ecNumber*3.4.21.22#kmValue*3.1#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*mutant enzyme FIXagamma225P, in presence of 200 mM Na+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*3.2#kmValueMaximum*#substrate*CH3SO2-D-Leu-Gly-Arg-4-nitroanilide#commentary*pH 7.5, 22&deg;C, in presence of 5 mM Ca2+ and 0.2 M RbCl#organism*Homo sapiens#ligandStructureId*5413#literature*684077#!ecNumber*3.4.21.22#kmValue*3.62#kmValueMaximum*#substrate*methoxycarbonyl-D-Nle-Gly-Arg-p-nitroanilide#commentary*rFIXa, at pH 7.4, in the presence of 33% v/v ethylene glycol#organism*Homo sapiens#ligandStructureId*31541#literature*95341#!ecNumber*3.4.21.22#kmValue*4.5#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*wild type enzyme FIXa, in presence of 5 mM Ca2+ and 185 mM Na+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*5.99#kmValueMaximum*#substrate*methylsulfonyl-D-hexahydrotyrosyl-Gly-Arg-p-nitroanilide#commentary*rFIXa, at pH 7.4, in the presence of 33% v/v ethylene glycol#organism*Homo sapiens#ligandStructureId*31545#literature*95341#!ecNumber*3.4.21.22#kmValue*7.3#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*mutant enzyme FIXagamma225P, in presence of 5 mM Ca2+ and 185 mM Na+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*7.9#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*mutant enzyme FIXagamma225P, in presence of 200 mM Ca2+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#!ecNumber*3.4.21.22#kmValue*8.7#kmValueMaximum*#substrate*4-methylsulfonyl-D-Leu-Gly-Arg-p-nitroanilide#commentary*wild type enzyme FIXa, in presence of 200 mM Ca2+#organism*Homo sapiens#ligandStructureId*4399#literature*669860#